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1. Introduction 
Global aquaculture has grow dramatically over the past 50 years to around 52.5 million 
tones in 2008 worth US$98.5 billon and accounting for around 50 per cent of the world´s 
food fish supply. Asia dominates this production, accounting for 89 per cent by volume and 
79 per cent by value, with China by far the largest producer (32.7 million tonnes in 2008). 
The rapid growth in the region has been driven by a variety of factors, including pre-
existing aquaculture practices, population and economic growth, relaxed regulatory 
framework and expanding export opportunities. 
Aquaculture development in Europe and North America was rapid during the 1980s-1990s 
but has since stagnated, probably owing to regulatory restrictions on sites and other 
competitive factors, although as markets for fish and seafood they have continue to grow 
(Bostock et al., 2010). 
In contrast to other animal production sectors, aquaculture is highly dynamic and 
characterized by an enormous diversity of species raised both in natural and artificial 
systems (Walter & Winton, 2010). Aquaculture began in Asia with the cultivation of 
freshwater fish, and use of the cultivation techniques currently extend to all continents, 
with a great diversity in the species raised (Subasinghe et al., 2009). Approximately 350 
different species are raised in farms, including 34 fish, 8 crustaceans, and 12 species of 
mollusks that have annual production levels exceeding 100,000 tons (Walter & Winton, 
2010). 
Shrimp cultivation areas have expanded the most. However, this industry faces major 
problems with bacterial diseases, and large quantities of chemical and antibiotic products 
are frequently used to counteract this (Le et al., 2005; Tu et al., 2008). 
2. Shrimp disease, one of the main threats facing aquaculture 
In aquaculture, bacterial diseases have emerged as a serious problem and represent the most 
important challenge facing this industry (Morales, 2004; Holmstrom et al., 2003). Bacterial 
microorganisms can also cause destructive infections, such as the diseases caused by 
bacteria of the Vibrio genus and the bacteria that cause necrotizing hepatopancreatitis 
(NHP). These are the main diseases responsible for infections in shrimp farms (Roque et al., 
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2001). The causative agent of necrotizing hepatopancreatitis (NHP) is a gram-negative, 
pleomorphic, obligate intracellular pathogen. The predominant is a non-flagellated, rod-
shaped, Rickettsia-like form, that occasionally, exhibits a transverse constricted zone 
indicative of replication by binary fission (Vincent & Lotz, 2007).  
Infections due to necrotizing hepatopancreatitis have been virtually eliminated in the 
Americas, but the International Office of Epizootics (IOE) has stated some concerns due to 
the potential that this disease possesses that could be extended to the entire world, because 
the mortalities caused in shrimp due to necrotizing hepatopancreatitis may include up to 
95% of the organisms infected in the pond, causing large losses during the crop cycle 
(Vincent & Lotz, 2007).  
The first infection by necrotizing hepatopancreatitis in a shrimp crop was reported on a 
farm in the state of Texas (United States of America) in 1985, and outbreaks have 
subsequently occurred in Peru, Ecuador, Venezuela, Brazil, Panama, Costa Rica, and 
Mexico, causing significant mortality. This disease is also known as granulomatous 
hepatopancreatitis or Texas necrotizing hepatopancreatitis, and the infection has been 
identified in species of Litopenaeus vannamei, Litopenaeus setiferus, Litopenaeus stylirostris, 
Farfantepenaeus aztecas, and Farfantepenaeus californiensis (Vincent & Lotz, 2007). 
The symptoms that shrimp infected with necrotizing hepatopancreatitis exhibit include a 
reduction in food ingestion, lethargy, an empty intestine, a flaccid body, darkening of the 
gills, an expansion of the chromatophores around the swimmerets leading to a darkened 
appearance, and marked atrophy of the hepatopancreas (Lightner, 1996).  
Bacteria of the Vibrio genus constitute the majority of the bacteria isolated from among those 
that cause disease and death, either when equilibrium is broken or the immune system is 
suppressed, and these can be due to some factors. Physico-chemical changes like salinity 
and temperature, and hypoxia have been reported to affect the immune response of shrimp 
and its susceptibility to pathogen bacteria. Water with low and high pH level, as well as 
those with low dissolved oxygen have been reported to decrease the total haemocyte count 
(THC) and phenol oxidase (PO) activity (Li & Chen, 2008).  
Systemic vibriosis, bacterial erosion, Zoea II syndrome, and “white ball” are some of the 
diseases affecting shrimp produced by bacteria of the Vibrio genus (Gómez-Gil et al., 
2001). Systemic vibriosis, also known as seagull syndrome, affects all farmable species of 
shrimp, as they may be susceptible to infection under stressful conditions. Vibrio species: 
harveyi, vulnificus, parahaemolyticus, and alginolyticus are all related to this disease 
(Morales, 2004).  
Bacterial erosion of the shell is present in all penaeid shrimp, juveniles and adults alike. It 
manifests with the appearance of brown or black stains in areas that have been eroded 
through the action of chitinolytic bacteria, such as Vibrio sp., Aeromonas sp., Spirillum sp., 
and Flavobacterium sp. The disease is self-limiting and generally disappears when the shrimp 
molt. If left untreated, it becomes more serious and may become a systemic infection 
(Morales, 2004).  
Zoea II Syndrome causes high mortality rates in the juvenile stage of shrimp. In Ecuador, 
the causal agent of this disease was found to be Vibrio harveyi, although other authors have 
reported the possible presence of intracellular bacteria. This infection was detected for the 
www.intechopen.com
 
The Use of Antibiotics in Shrimp Farming 
 
201 
first time in 1993 in farms of Litopenaeus vannamei in Ecuador, Mexico, and the United States 
(Morales, 2004).  
“White ball” disease causes the appearance of small balls, arising from desquamated 
hepatopancreatic cells or to hypertrophied and rounded hepatocytes that appear as 
spherical formations. It is believed that these balls are caused by toxins produced mainly by 
Vibrio spp. The species of Vibrio related to this syndrome are Vibrio alginolyticus and Vibrio 
harveyi (Gómez-Gil et al., 2001; Vandenberghe et al., 1999). 
A significant limitation to the industry is loss of stock through bacterial disease. Traditional 
methods to combat disease with antibiotics have been questioned and alternatives have 
been sought. The modern aquaculture industry demands alternative prophylacts that may 
help to keep a microbiologically healthy environment, resulting in better production and 
higher profits. Within this context, the probiotics seem to be a very promising alternative for 
the management of disease in aquaculture (Sáenz, et al., 2009) Another form is with the 
reduction in stocking density. 
3. Antibiotics used in the cultivation of shrimp 
Antibiotics are commonly used in aquaculture during the production cycle, both in the 
larval and growth phases. The use of antibiotics in aquaculture is associated with 
environmental and human health problems, including bacterial resistance, persistence of the 
disease in the aquatic environment, and effects on the biogeochemical composition of the 
sediment. The accumulation of antibiotic residues in the edible tissues of shrimp may also 
alter human intestinal flora and cause food poisoning or allergy problems (Ma et al., 2006). 
The antibiotics most frequently used in aquaculture to combat bacterial diseases include 
oxytetracycline, florfenicol, sarafloxacin, and enrofloxacin (Roque et al., 2001; Soto-
Rodríguez et al., 2006). Globally, other antibiotics such as chlortetracycline, quinolones, 
ciprofloxacin, norfloxacin, oxolinic acid, perfloxacin, sulfamethazine, gentamicin, and 
tiamulin are used (Holmstrom et al., 2003).  
3.1 Oxytetracycline 
Oxytetracycline is widely employed to treat bacterial infections in aquaculture farms, such 
as vibriosis and furunculosis (Capone et al., 1996; Prescott et al., 2000; Reed et al., 2006; 
Wang et al., 2004). It belongs to the tetracycline group, which exerts antimicrobial action 
against both Gram (-) and (+) bacteria, ricksettsias, mycoplasmas, and others (Gómez-Gil et 
al., 2001). Tetracyclines are produced by Streptomyces spp., which possess determinants for 
resistance to this class of antibiotics. 
Oxytetracycline is a bacteriostatic antibiotic that exerts its antimicrobial effect against 
protein synthesis, by bonding directly to the S7 protein of the 30S subunit of the bacterial 
ribosome, thereby impeding the bonding of aminoacyl-tRNA (aminoacyl transfer RNA) to 
the A-site of the ribosome. This prevents the addition of amino acids to the growing peptide 
chain (Chambers, 2004; Isidori et al., 2005; Jara, 2007). In order for oxytetracycline to interact 
with its target site, it needs to pass through the external membrane via passive diffusion 
through the OmpF and OmpC pores, and through the cytoplasm membrane via an energy-
dependent process (Jara, 2007). 
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3.2 Enrofloxacin 
Enrofloxacin was developed as an antimicrobial agent during the 1980s for exclusive use in 
veterinary medicine and has proven to be effective in the treatment of bacterial diseases that 
affect aquaculture organisms. Enrofloxacin is a derivative of nalidixic acid. It has a basic 
dihydroquinoline (4-quinolone ring) chemical core with an ethyl group at the 4th position, 
favoring its absorption and availability. It is primarily lipophilic and has a low molecular 
weight, favoring tissue penetration. The mechanism of enrofloxacin acts at the level of the 
cellular nucleus, inhibiting DNA synthesis. During the multiplication phase of the bacteria, 
the DNA folds and unfolds alternately. This process is controlled by the enzyme DNA 
gyrase, which is inhibited by enrofloxacin, causing a collapse of bacterial metabolism and 
preventing the genetic information from being copied, thus causing the bacteriocidal effect 
(Williams et al., 2002).  
The information related to this antibiotic for the most widely grown shrimp species such as 
Litopenaeus vannamei is scarce, but pharmacokinetic studies on enrofloxacin have been 
carried out using other species, such as crab (Scylla serrata), tilapia (Oreochromis niloticus), 
black shrimp (Penaeus monodon), Chinese shrimp (Penaeus chinensis), and European seabass 
(Dicentrarchus labrax) (Intorre et al., 2000; Tu et al., 2008; Wen et al., 2007; Xu et al., 2006). It is 
important to note that the pharmacokinetic results for enrofloxacin obtained for these 
species should not be extrapolated to other aquatic species, because each organism 
possesses a different metabolism, and the cultivation conditions may have a significant 
influence over the kinetic behavior displayed by the antibiotic. 
None of the fluoroquinolones included enrofloxacin is approved for use in shrimp in the 
United States. Their potential use in other countries, such as Mexico, as well as the 
potential for extra-label use in the United States provides a need for efficient methods to 
monitor food supplies for the presence of fluoroquinolones residues (Schneider et al., 
2005). 
3.3 Ciprofloxacin 
Ciprofloxacin is the main metabolite of Enrofloxacin and is active against a broad spectrum 
of aerobic Gram (-) bacteria, including enteric pathogens such as Pseudomonas and Serratia 
marcescens. It is also active against Gram (+) pathogens, even when these bacteria have 
developed resistance to other antibiotics, such as penicillin (Wen et al., 2007). It is not active 
against anaerobic bacteria and may be used occasionally, in combination with other 
antibacterial agents, for the treatment of mycobacterial infections. 
The antibacterial effects of ciprofloxacin arise from its inhibition of Topoisomerase IV and 
bacterial DNA gyrase, which act by cleaving the DNA of the bacterial chromosome and 
rejoining the ends once a superhelix is formed (Banerjee et al., 2007). When these enzymes 
are inhibited, bacterial cell multiplication is interrupted.  
3.4 Florfenicol 
This fluorinated antibiotic, derived from thiamphenicol, is a potent and broadly acting 
bacteriostatic agent. It is effective in the treatment of infections caused by Pasteurella 
piscicida, Aeromonas salmonicida, Vibrio anguillarum, and Edwardsiella tarda. Its chemical 
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structure is very similar to that of chloramphenicol, and florfenicol is effective against 
bacteria that have developed the ability to deactivate other drugs, such as thiamphenicol 
and chloramphenicol. Pharmacokinetically, florfenicol use has been reported among some 
species of fish such as Atlantic salmon (Salmo salar), in which a bioavailability of more than 
95% is present, exhibiting a good distribution among all of the organs and tissues. Its half-
life in fish is less than 15 h (Yanong & Curtis, 2005). However, published information for 
shrimp is scarce, meaning that the kinetic behavior of this compound among these 
crustaceans has not yet been completely elucidated.  
3.5 Sarafloxacin 
This is a white or slightly yellow crystalline solid with the chemical name 6-fluoro-1-(4-
fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid. Its solubility is 0.034 
mol/L at pH 1, and its molecular weight is 385 (King et al., 2000; Oliphant et al., 2002). Two 
fluoroquinolones have been approved by the Food and Drug Administration (FDA) in the 
United States for use in the production of animal-derived food products. Sarafloxacin was 
approved in August 1995 for the treatment of infections caused by Escherichia coli in poultry 
(turkeys and chickens) but, along with other fluoroquinolones, has not been authorized by 
the Food and Drug Administration for use as a therapeutic agent in aquaculture (Roybal et 
al., 2002; Nakata et al.,2005).  
The normal dosage used in farm animals is 10 mg kg-1, and the drug is administered in 
drinking water. A Maximum Residue Level (MRL) has not been established for cow’s milk 
or chicken muscle (King et al., 2000; Oliphant et al., 2002).  
3.5.1 1
st
 Generation quinolones 
These are used exclusively as urinary antiseptics because they do not have sufficient serum 
levels and are actively eliminated with urine. All are administered orally. 
3.5.2 2
nd
 Generation quinolones 
These are monofluoride quinolones. Compared to 1st generation quinolones, these exhibit 
more potent activity, a greater bacterial spectrum, a longer half-life, and, with the exception 
of norfloxacin and enrofloxacin, they achieve good serum levels, making it possible to treat 
systemic infections. Ciprofloxacin, Ofloxacin, and Perfloxacin can be administered both 
orally and parenterally.  
3.5.3 3
rd
 Generation quinolones 
These are bi- and trifluoride fluoroquinolones. Some have a greater half-life and others have 
a greater antibacterial spectrum, in some cases including Gram (+) bacteria (mainly 
streptococci), intracellular bacteria (Chlamydia, mycoplasma, mycobacteria, etc.), and 
anaerobic bacteria. 
3.5.4 4
th
 Generation quinolones 
This group has improved activity against Gram (+) bacteria and anaerobic bacteria (King et 
al., 2000; Oliphant et al., 2002). 
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4. Studies on the accumulation and elimination of enrofloxacin and 
oxytetracycline antibiotics among Litopenaeus vannamei shrimp 
The exposure of the consumer to antibiotic residues in seafood is of great importance for 
health. Information related to residues of oxytetracycline, enrofloxacin and its metabolite 
ciprofloxacin in Litopenaeus vannamei tissues is very scarce, even though this species is 
among the most highly valued for its commercialization and oxytetracycline and 
enrofloxacin are frequently employed when farming this species. 
However, pharmacokinetic and bioavailability studies of antimicrobial agents in farmed 
shrimp are important in order to determine optimal dosage regimens and formulations, to 
establish safe withdrawal periods, and to minimize the environmental effects of the drug 
used in aquaculture. 
The low analyte concentrations normally present (ng g-1, ng mL-1), the complexity of 
matrices and the diverse physico-chemical properties that antibiotics may present make 
their determination difficult, and highly sensitive, selective methods are necessary for 
monitoring antibiotics in the aquatic organisms (Hernández et al., 2007). The liquid 
chromatography is the most widely used method, for quantitative analysis of antibiotics. 
The purpose of introduce the chemical method about high-performance liquid 
chromatography was precise quantitative determination of antibiotics residues in the 
muscle tissues and hepatopancreas to shrimp. Following this analytical approach, the 
requirements for veterinary monitoring concerning to antimicrobials residues would be 
fulfilled. Previously only microbiological methods were used, which gave only orientation 
results.  
In a study performed in our laboratory (unpublished data), an attempt was made to 
determine the accumulation and elimination of enrofloxacin and its metabolite ciprofloxacin 
in a crop of Litopenaeus vannamei using high-performance liquid chromatography after 
administering a diet medicated with enrofloxacin at a level of 200 mg kg-1 for 14 days. 
Subsequently, a diet without the antibiotic was administered for 16 days. The study was 
carried out under controlled laboratory and farm conditions. It was found that the 
maximum concentrations (Cmax) reached for enrofloxacin in the muscle and hepatopancreas 
under laboratory conditions were 0.54±0.26 μg g-1 and 3.52±1.9 μg g-1, respectively. For 
ciprofloxacin, levels of 0.18±0.13 μg g-1 and 1.05±0.20 μg g-1 were reached in the muscle and 
hepatopancreas, respectively.  
In the farm study, Cmax enrofloxacin levels of 0.36±0.17 μg g-1 and 1.60±0.82 μg g-1 were 
reached in the muscle and hepatopancreas, respectively. For ciprofloxacin, these were 
0.03±0.02 and 0.36±0.08 μg g-1, respectively. Once the medicated diet was suspended, 
enrofloxacin and ciprofloxacin residues in the tissues decreased, requiring four to ten days 
for the levels of both antibiotics to be undetectable in the muscle and six to fourteen days for 
elimination from the hepatopancreas. 
Under controlled conditions, the greatest accumulations of the antibiotic and its metabolite 
were reached, showing a reduction of 33% in the muscle and 55% in the hepatopancreas 
when compared with the levels reached under farm conditions. For ciprofloxacin, the 
reduction was 66% in both tissues. It is important to relate the accumulations levels reached 
with the Minimal Inhibitory Concentration of the drug that can treat bacterial infections 
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among shrimp, to determine whether this antibiotic is effective for the control of these 
diseases.  
Oxytetracycline, another of the most widely used antibiotics both in fish and shrimp farms, 
was studied in relation to its accumulation in shrimp tissues (muscle and hepatopancreas), 
and this was related to its effect in the inhibition of Vibrio bacteria through determination of 
the Minimal Inhibitory Concentration. In addition, the time of elimination of the antibiotic 
from shrimp tissues was established. 
To perform this study, ponds on a farm of Litopenaeus vannamei were employed. The shrimp 
were treated for 14 days with food that contained a theoretical oxytetracycline concentration 
of 5000 mg kg-1. Next, an antibiotic-free diet was administered for 16 days. The shrimp were 
sampled every third day. Vibrio bacteria were isolated in the muscle and hepatopancreas of 
the shrimp, counted and expressed as CFU, and strains belonging to the Vibrio genus were 
identified at the molecular level.  
The results obtained show an average Cmax for oxytetracycline in the shrimp tissues of 
31.32±3.44 μg g-1 in the muscle and 274.81±62.35 μg g-1 in the hepatopancreas. The 
accumulation levels reached in some of the tissue samples in the treatment stage were 
greater than the Minimal Inhibitory Concentration determined for oxytetracycline, in the 
range of 0.75-100 μg mL-1. Vibrio parahaemolyticus was identified in 48% of the strains 
analyzed in the crop system, and no strain was positive for toxigenic Vibrio cholerae O1.  
The withdrawal times necessary for the oxytetracycline residues to be eliminated were ten 
days for the hepatopancreas and sixteen days for muscle. Under controlled conditions in the 
laboratory, a diet was administered to Litopenaeus vannamei shrimp that contained 5000 mg 
Kg-1 of oxytetracycline for 14 days. The accumulation levels (Cmax) for oxytetracycline were 
33.54±11.19 μg g-1 in the muscle (Fig. 1), 194.37±16.11 μg g-1 in the hepatopancreas (Fig. 2), 
and 18.79±5.87 μg mL-1 in the hemolymph. The elimination time for oxytetracycline were six 
to ten days for all tissues. 
The results obtained in the application of these antibiotics demonstrates the importance of 
applying appropriate therapies with antibiotics, seeking greater effectiveness for the control 
of bacterial infections, and highlighting the importance of respecting the withdrawal times 
for each antibiotic, with the purpose of eliminating the residual presence of these 
compounds from the edible tissues and from the cultivation system in general (to decrease 
the development of antibiotic resistance in the bacteria). 
5. Factors to consider when using antibiotics in aquaculture 
Antibiotics must not be used as a preventative measure, since bacteria very rapidly develop 
resistance to them, leading to their ineffectiveness. Chemical agents should only be applied 
if there is an appropriate diagnosis of the situation and always under previously established 
control protocols. To evaluate the impact of antibiotic administration, the usage standards, 
the hydrology of the area, and the physical-chemical properties of the water should be 
known (Páez-Osuna et al., 2003; Nakata et al., 2005). Best practices in aquaculture 
management should be prioritized to avoid the entrance of pathogens into the shrimp 
cultivation systems, and antibiotics should only be administered as a last resort (Chávez-
Sánchez & Higuera-Ciapara, 2003). 
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Fig. 1. Muscle oxytetracycline levels -time profiles in the shrimp Litopenaeus vannamei after 
an oral OTC dosage through a medicated feed. The vertical bars represent the Standard 
Error (n=3). A: treatment period, B: withdrawal period. 
The most frequent administration route for antibiotics in shrimp is oral, in which the 
antibiotic is incorporated in the feed with subsequent exposure to the extremely aggressive 
aquatic environment. For this reason, it is important that the antibiotic be contained within a 
pellet to maintain its stability and protect it from factors such as leaching and binding to 
trivalent and divalent cations (Cabello, 2004).  
It must be certain that the shrimp will eat the food when the antibiotic therapy is applied, 
because the disease will otherwise not be treated, the environment will be contaminated, 
and the emergence of bacterial resistant strains will be favored. The consumption of food by 
the farmed organisms may decrease during the molting period, due to environmental 
factors, or factors related to the infections, reducing the quantity of the antibiotic ingested 
(Cuzon et al., 2004).  
The water temperature of the farm ponds is a critical point to consider, because parameters 
such as the maximum concentration, distribution volume, and rate of elimination of the  
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Fig. 2. Hepatopancreas oxytetracycline levels –time profiles in the shrimp Litopenaeus 
vannamei after an oral OTC dosage through a medicated feed. The vertical bars represent the 
Standard Error (n=3). A: treatment period, B: withdrawal period. 
antibiotic may be affected. The pH, oxygenation, salinity, stage of disease, climatic changes, 
and presence of natural food in the ponds are other factors that affect antibiotic therapies 
among aquatic organisms (Chávez & Montoya, 2004; Montoya, 2002).  
The use of pharmacological agents, antibiotics, and other chemical agents should be 
considered as methods of last resort in shrimp farming and aquaculture in general. None of 
the antibiotics is approved for use in shrimp in the United States. The medicated feed is 
used in an extralabel manner only for treatment of minor species as defined in the Code of 
Federal Regulations (21 CFR 514.1(d)(1)(ii). In an aquatic species, the extralabel use of 
medications added to feed in limited to products approved for use in other aquatic species 
(FDA, 2001). 
6. The development of bacterial resistance 
Drug resistance in when a formerly effective drug dose is no longer effective. This can be a 
natural resistance or an acquired resistance. Resistance arises mainly by natural selection, 
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the replication of a naturally resistant strain after the drugs has killed all of the susceptible 
strains. Since mutagenic drugs generally are not used, resistance by drug-induced mutation 
seldom occurs. Drug resistance also can develop from gene transfer or gene amplification 
(Albert, 1985). 
The most worrying effect of the use of antibiotics in aquaculture production and its 
relationship with human health is the generation of resistant bacteria strains and the transfer 
of this resistance from the aquatic environment to land, where strains that are highly 
immune to antibiotics may originate that are capable of causing disease among humans. The 
transfer of resistance may occur through mechanisms as simple as the consumption of 
seafood products that contain bacteria that are resistant to various antibiotics (Gräslund & 
Bengtsson, 2001).  
It has been demonstrated that the use and abuse of antibiotics has given rise to multiple 
resistance among microbial populations associated with shrimp production. Various studies 
have shown that antibiotics persist in the sediment and aquatic environment for several 
months after their administration (Matyar et al., 2008), and that these may affect native 
bacterial community in detrimental to the ecosystem since this community plays key roles in 
biogeochemical processes. Some antimicrobials can inhibit important microbial processes as 
denitrification or primary production by cyanobacteria (Garcia-Armisen et al., 2011).  
The capacity of the microorganisms to reduce sulfates may also be reduced (Páez-Osuna et 
al., 2003), affecting the quality of the sediment and the environment (Ma et al., 2006), thereby 
promoting the proliferation of resistant bacterial strains or pathogens (Capone et al., 1996; 
Hektoen et al., 1995; Tendencia & De la Peña, 2002;), which may place the viability of shrimp 
crops at risk. 
It is estimated that between 15 and 40% of the administered medicated diet is not ingested by 
the organisms and remains in the substrates. Another part of the medication is not absorbed 
during its passage through the intestinal tract of the organism and returns to the environment 
in fecal matter. The amount of antibiotic transferred to the environment varies from 1% 
(chloramphenicol) to 90% (oxytetracycline) (Capone et al., 1996). Hektoen et al. (1995) reported 
that approximately 70-90% of the antibiotic used in the therapy of farmed organisms ends up 
in the environment and sediment, and a high percentage exhibits antibacterial activity. It has 
been reported that residues of oxolinic acid and oxytetracycline are very persistent under 
certain conditions, with half-lives exceeding 100 days (Samuelsen et al., 1992). 
Three mechanisms of resistance to tetracycline have been described: (1) decreased 
intracellular accumulation due to either impaired influx or increased efflux by an active 
transport protein pump; (2) ribosome protection due to production of protein that interfere 
with tetracycline binding to the ribosome; and (3) enzymatic inactivation of tetracyclines. 
The most important of these is production of an efflux pump. The pump protein is encoded 
on a plasmid and may be transmitted by transduction or by conjugation. Because these 
plasmids commonly encode resistance genes for other drugs, eg, aminoglycosides, 
sulfonamides and chloramphenicol, tetracycline resistance is marker for resistance to 
multiple drugs (Tenover, 2006).  
Some studies have demonstrated that the concentrations of oxytetracycline in the sediment 
after therapy may range from 0.4 to 495 μg g-1. Therapeutic dosages of oxytetracycline in fish 
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may cause sub-lethal effects, including alteration of the levels of immunoglobulin in the 
serum and suppression of the phagocytic response and macrophages (Uyaguari et al., 2009).  
International regulations regarding the use of antibiotics in aquaculture have established a 
list of prohibited products (Stolker & Brinkman, 2005). Shrimp with traces of these products 
are subject to measures against their importation. The strongest restrictions are on the use of 
chloramphenicol, dimetridazole, furazolidone, nitrofurazone, other nitrofurans, and 
fluoroquinolones, and these antibiotics should not be used at any stage of the production 
process (Defoirdt, et al., 2007; Tittlemier et al., 2007). 
Epidemiological and molecular assays have indicated that genes mediating resistance might 
be transmitted from aquatic bacteria to bacteria capable of producing infections among 
humans and terrestrial animals. This demonstrates that the aquatic and terrestrial 
compartments lack borders with respect to the flow of resistance genes and that the 
resistance phenomenon is global, because the use of antibiotics in an environment will have, 
over time, repercussions in other, apparently distant, ecosystems (Cabello, 2002; Rhodes et 
al., 2000). To decrease the contamination of the environment and bacterial resistance, 
appropriate aquaculture production practices must be carried out, and biosecurity measures 
must be applied to reduce outbreaks of disease and the propagation of pathogenic agents 
(Kemper, 2008). 
Global efforts are needed to promote more judicious use of antibiotics in aquaculture and 
the new strategies to control phatogenic bacteria are needed to make the industry more 
sustainable. However, it is not always economically feasible to culture the organism in the 
most optimal conditions, so there will always be a risk to infection and a need for effective 
biocontrol techniques (Defoirdt, et al., 2007). 
It is important to highlight that the application of highly sensitive analytical methodologies 
is indispensably in measuring the concentrations of antibiotics and their metabolites with 
certainty in the distinct tissues of aquaculture products. This would help in establishing 
regulations that protect the environment, generating products that are safe for human 
consumption, and allowing the growth of aquaculture. 
A practical use of the pharmacokinetic data is the possibility to design dosage regimens in 
which levels of a specific drug can be maintained above the Minimum Inhibitory 
Concentration and below toxic effects by means of repeated dosages. However, this method 
requires information on Minimal Inhibitory Concentration established for bacterial 
pathogens of interest. Although there are reports on available Minimal Inhibitory 
Concentration for bacterial strains potentially pathogens to shrimp species, they reveal a 
wide range of values. Takahashi et al., (1985) reported that Minimal Inhibitory 
Concentration of oxytetracycline against 49 strains of Vibrio sp., range from 0.1 to 12.5 µg 
mL-1. Monhey et al., (1992) found the Minimal Inhibitory Concentration to be in the range of 
2.0 µg mL-1 or less for Vibrio isolated mainly from American shrimp. Furthermore, Roque et 
al., (2001) in their study of 144 isolated of Vibrio reported a Minimal Inhibitory 
Concentration of 304.0 µg mL-1 for oxytetracycline with a range from 0.26 to 1064 µg mL-1. 
Given the wide range of Minimal Inhibitory Concentration it is recommended to isolate 
local bacterial strains and evaluate their Minimal Inhibitory Concentration. Additionally, it 
still requires performing such studies in natural farming conditions (Gómez-Jimenez et al., 
2008).  
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7. Conclusion 
Scientific studies have been conclusive with respect to the health risk that the massive and 
unlimited use of antibiotics in aquaculture represents. When health certifications are 
implemented for aquaculture products demanded by domestic and foreign markets, the 
control over the use of these compounds needs to be increased, together with other aspects 
of primary importance such as food safety, protection of the environment, and the health of 
farmed organisms. These aspects should be considered and resolved through the 
implementation of Best Management Practices. 
8. Acknowledgment 
The authors wish to express their gratitude to PhD. Evelia Acedo Félix and Q.B. Rosalva 
Pérez Morales of the Molecular Microbiology Laboratory, for their technical support and 
contribution to help facilitate the completion of the project. Furthermore, we acknowledge 
the kind donation of the shrimp from the farm “La Borbolla”, specialty engineers Roberto 
Federico Aguayo Valenzuela and César Patiño Patiño, and the technical assistance of Biol. 
Adolfo Pérez Álvarez and Tech. Juan Carlos Gastélum Domínguez.  
9. References 
Albert, A. (1985). Drug resistance and synergism; Chemotherapy. In: The organic chemistry of 
drug design and drug action,. Richard B. Silverman (Ed), pp. 149-150, Academic Press, 
ISBN 0-12-643730-0, San Diego, CA. 
Banerjee, S.; Devaraja, T.; Shariff, M. & Yusoff, F. (2007). Comparison of four antibiotics with 
indigenous marine Bacillus spp. in controlling pathogenic bacteria from shrimp and 
Artemia. Journal of Fish Diseases, vol.30, pp.383–389. 
Bostock, J., McAndrew, B., Richards, R., Jauncey, K., Telfer, T., Lorenzen, K., Little, D., Ross, 
L., Handisyde, N., Gatward, I. & Corner R. (2010). Aquaculture:global status and 
trends. Philosophical Transactions of the Royal Society B, vol.365, pp.2897-2912. 
Cabello, F. C. (2004). Antibióticos y Acuicultura en Chile: consecuencias para la salud 
humana y animal. Academia de Medicina, Instituto de Chile, vol.132, pp.1001-1006. 
Capone, G. D.; Weston, P. D.; Miller, V. & Shoemaker, C. (1996). Antibacterial residues in 
marine sediments and invertebrates following chemotherapy in aquaculture. 
Aquaculture, vol. 145, pp.55-75. 
Chambers, H. F. (2004). Chloramphenicol, Tetracyclines, Macrolides, Clindamycin and 
Streptogramins, In: Basic and clinical pharmacology, Katzung B. G. (ed), pp. 754-763, 
MacGraw-Hill, ISBN 0-07-141092-9, New York. 
Chávez-Sánchez, M. C. & Higuera-Ciapara, I. (2003). Manual de Buenas Prácticas de 
Producción Acuícola de Camarón para la Inocuidad Alimentaria. Servicio Nacional 
de Sanidad Inocuidad y Calidad Agroalimentaria (SENASICA), ISBN 968-5384-04-
5, Mazatlán, Sinaloa, México. 
Chávez, S. M. C. & Montoya, R. L. Medidas de bioseguridad para evitar la introducción y 
dispersión de enfermedades virales en granjas camaronícolas, VII Simposium 
Internacional de Nutrición Acuícola, Hermosillo, Sonora. México, Noviembre, 2004. 
Cuzon, G.; Lawrence, A.; Gaxiola, G.; Rosas C. & Guillaume, J. (2004). Nutrition of 
Litopenaeus vannamei reared in tanks or in ponds. Aquaculture, vol. 235, pp.513-551. 
www.intechopen.com
 
The Use of Antibiotics in Shrimp Farming 
 
211 
Defoirdt, T.; Boon, N.; Sorgeloos, P.; Verstraete, W. & Bossier, P. (2007). Alternatives to 
antibiotics to control bacterial infections: luminescent vibriosis in aquaculture as an 
example. TRENDS in Biotechnology, vol.25, pp.472-479. 
FDA. (2001). United States FDA. Aquaculture drugs (a chemical hazard). In: Fish and fishery 
products hazards and controls guidance. 3rd ed. Washington, DC: US FDA, Centre for 
Food Safety and Applied Nutrition, Office od Seafood, pp.127-144. 
Garcia-Armisen, T., Vercammen, K., Passerat, J., Triest, D., Servais, P. & Cornelis, P. (2011). 
Antimicrobial resistance of heterotrophic bacteria in sewage-contaminated rivers. 
Water Research, vol.45, pp.788-796. 
Gräslum, S. & Bengtsson, B. (2001). Chemical and biological products used in south-east 
Asian shrimp farming and their potential impact on the environment a review. The 
Science of the Total Environment, vol. 280. pp. 93-131. 
Gómez-Gil, B.; Roque, A. & Guerra, F. A. (2001). Enfermedades infecciosas más comunes en 
la camaronicultura en México y el impacto del uso de antimicrobianos. In: 
Camaronicultura y Medio Ambiente. México: Unidad Académica Mazatlán. Páez-Osuna 
F. (ed). Instituto de Ciencias del Mar y Limnología. Universidad Nacional 
Autónoma de México. Mazatlán, Sin. pp. 315-346. 
Gómez-Jimenez, S.; Espinosa-Plascencia, A.; Valenzuela-Villa, F. & Bermúdez-Almada, M.C. 
(2008). Oxytetracycline (OTC) accumulation and elimination in hemolymph, 
muscle and hepatopáncreas of white shrimp Litopenaeus vannamei following and 
OTC-Feed therapeutic treatment. Aquaculture, vol. 274, pp.24-29. 
Hektoen, H.; Berge, J.A.; Hormazabal, V. & Yndeslad, M. (1995). Persistence of antibacterial 
agents in marine sediments. Aquaculture, vol.133, pp.175-184. 
Hernández, F.; Sancho, V. J.; Ibáñez, M. & Guerrero, C. (2007). Antibiotic residue 
determination in environmental waters by LC-MS. Trends in Analytical Chemistry, 
vol.26, No.6, pp.466-485. 
Holmström, K.; Gräslund, S.; Wahlström, A.; Poungshompoo, S.; Bengtsson, B. E. & 
Kautsky, N. (2003). Antibiotic use in shrimp farming and implications for 
environmental impacts and human health. International Journal of Food Science and 
Technology, vol. 38, pp.255-266. 
Intorre, L.; Cecchini, S. & Bertini, S. (2000). Pharmacokinetics of enrofloxacin in the seabass 
(Dicentrarchus labrax). Aquaculture, vol.182, pp.49–59. 
Isidori, M.; Lavorgna, M.; Nardelli, A.; Pascarella L. & Parrella, A. (2005). Toxic and 
genotoxic evaluation of six antibiotics on non-target organisms. The Science of the 
Total Environment, vol.346, pp.87-98. 
Jara, M. A. (2007). Tetraciclinas: Un modelo de resistencia antimicrobiana. Avances en 
Ciencias Veterinarias, vol.22, pp.49-55. 
Kemper, N. (2008). Veterinary antibiotics in the aquatic and terrestrial environment. 
Ecological Indicators, vol.8, pp.1-13. 
King, D.E.; Malone, R. & Lilley, S. H. (2000). New classification and update on the quinolone 
antibiotics. American Family Physician, vol.61, pp.2741-2748. 
Le, X.T. ; Munekage, Y. & Kato, S. (2005). Antibiotic resistance in bacteria from shrimp 
farming in mangrove areas. Science of the Total Environment, vol.349, pp.95-105. 
Li, C. & Che, J. (2008). The immune response of white shrimp Litopenaeus vannamei and its 
susceptibility to Vibrio alginolyticus under low and high pH stress. Fish & Shellfish 
Immunology, vol.25, pp.701-709. 
www.intechopen.com
 
Health and Environment in Aquaculture 
 
212 
Lightner, D. V. (1996). A Handbook of pathology and diagnostic procedures of diseases of cultured 
penaeid shrimp, World Aquaculture Society. Department of Veterinary Science, 
University of Arizona, Tucson, Az.  
Ma, D.; Hu, Y.; Wang, J.; Ye, S. & Li, A. (2006). Effects of antibacterials use in aquaculture on 
biogeochemical processes in marine sediment. The Science of the Total Environment, 
vol. 367, No.1, pp.273-277. 
Matyar, F., Kaya, A. & Dinçer, S. (2008). Antibacterial agents and heavy metal resistance in 
Gram-negative bacteria isolated from seawater, shrimp and sediment in 
Iskenderun Bay, Turkey. Science of the Total Environment, vol. 407, pp.279-285. 
Monhey, L.L., Bell, T.A. & Lightner, D.V. (1992). Shrimp antimicrobial testing, I. In vitro 
susceptibility of thirteen Gram-negative bacteria to twelve antimicrobials. Journal of 
Aquatic Animal Health, vol.4, pp.257-261. 
Montoya, V. N. (2002). Residuos de antibióticos en camarones: límites residuales y detección 
de anfenicoles, In: Centro Nacional de Acuicultura e Investigaciones Marinas “Edgar 
ArellanoM.” (CENAIM), Julio, 2011, 
www.cenaim.espol.edu.ec/publicaciones/quincenal/bquinc54.pdf. Boletin 54. 
Morales, C. M. S. (Ed). (2004). Enfermedades del camarón, Editorial Trillas, ISBN-968-24-7112-5, 
México, D. F. 
Nakata, H.; Kannan, K.; Jones, D. P. & Giesy, P. J. (2005). Determination of fluoroquinolones 
antibiotics in wastewater effluents by liquid chromatography-mass spectrometry 
and fluorescente detection. Chemosphere, vol.58, pp.759-766. 
Oliphant, C.M.; Pharma, D.; Gary, M. & Green, M. D. (2002). Quinolones: a comprehensive 
review. American Family Physician, vol.65, pp.455-464. 
Páez-Osuna, F.; Gracia, A.; Flores-Verdugo, F.; Lyle-Fritch, L. P.; Alonso-Rodriguez, R.; 
Roque, A. & Ruiz-Fernandez, A. C. (2003). Shrimp aquaculture development and 
the environment in the Gulf of California ecoregion. Marine Pollution Bulletin, 
vol.46, No.7, pp.806-815. 
Prescott, J. F.; Baggot, J. D. & Walter, D. R. (2000). Tetracyclines and Glycylcyclines, In: 
Antimicrobial Teraphy in Veterinary Medicine. Giguére, S.; Prescott, J.F.; Baggot, J.D.; 
Walker, R.D.; Dowling, P.M. (Ed), pp.231, Blackwell Publishing, ISBN-0813806569, 
Iowa State. 
Reed, L. A.; Siewicki, T. C. & Shah, A. C. (2006). The biopharmaceutics and oral 
bioavailability of two forms of oxytetracycline to the white shrimp, Litopenaeus 
setiferus. Aquaculture, vol.258, pp.42-54. 
Rhodes, G.; Huys, G.; Swings, J.; Mc Gann, P.; Hiney M. & Smith, P. (2000). Distribution of 
oxytetracycline resistance plasmids between aeromonads in hospital and 
aquaculture environments: Implication of Tn1721 in dissemination of the 
tetracycline resistance determinant Tet A. Applied Environmental Microbiology, 
vol.66, pp.3883-3890. 
Roque, A.; Molina, A. A.; Bolán, M. C. & Gómez, G. B. (2001). In vitro susceptibility to 15 
antibiotics of vibrios isolated from penaeid shrimps in Northwestern Mexico 
International Journal of Antimicrobial Agents, vol.17, pp.383–387. 
Roybal, J. E.; Walker, C. C.; Pfenning, P.A.; Turnipseed, B. S.; Storey, M. J.; Gonzalez, A. S. & 
Hurlbut, J.A. (2002). Concurrent determination of four fluoroquinolonas in catfish, 
shrimp, and salmon by liquid chromatography with fluorescence detection. Journal 
of Association Official Analytical Chemistry International. vol.85, No.6, pp.1293-1301. 
www.intechopen.com
 
The Use of Antibiotics in Shrimp Farming 
 
213 
Sáez, M. A.; Díaz-Rosales, P.; Chabrillón, M.; Smidt, H.; Arijo, S.; León-Rubio, J. M.; Alarcón, 
F. J.; Balebona, M. C.; Moriñigo, M. A.; Cara, J. B. & Moyano, F. J.(2009). Effect of 
dietary administration of probiotics on growth and intestine functionality of 
juvenile Senegalese sole (Solea senegalensis, Kaup 1858). Aquaculture Nutrition, 
vol.15, pp.177-185. 
Samuelsen, O.B. (1992). The fate of antibiotics/chemotherapeutants in marine aquaculture 
sediments. In: Chemotherapy in Aquaculture: From Theory to Reality. Michel, C. & 
Alderman, D.J. (Ed), pp. 87-95, Office International des Epizooties, Paris, France. 
 Schneider, J. M. ; Vazquez-Moreno, L.; Bermudez-Almada, M.C.; Barraza-Guajardo R. & 
Ortega-Nieblas, M. (2005). Multiresidue determination of fluoroquinolones in 
shrimp by liquid chromatography-fluorescence-mass spectrometry. Journal of 
AOAC International, vol. 88, No.4, pp.1160-1166. 
Soto-Rodríguez, S.; Armenta, M. & Gomez-Gil, B. (2006). Effects of enrofloxacin and 
florfenicol on survival and bacterial population in an experimental infection with 
luminescent Vibrio campbellii in shrimp larvae of Litopenaeus vannamei. Aquaculture, 
vol.255, pp.48-54. 
Stolker, A. A. M. & Brinkman, U.A. Th. (2005). Analytical strategies for residues analysis of 
veterinary drugs and growth-promoting agents in food-producing animals-a 
review. Journal of Chromatography A, vol.1067, pp.15-53. 
Subasinghe, R.; Soto, D. & Jia, J. (2009). Global aquaculture and its role in sustainable 
development. Reviews in Aquaculture, vol.1, pp.2-9. 
Takahashi, Y., Itami, T., Nakagawa, A., Nishimura, H. & Abe, T. (1985). Therapeutic effects 
of oxytetracycline trial tablets against vibriosis in cultured kuruma prawns Penaeus 
japonicus Bate. Bulletin of the Japanese Society for the Science of Fish/Nissuishi vol.51, 
No.10, pp.1639-1643. 
Tittlemier, S. A.; Van de Riet, J.; Burns, G.; Potter, R.; Murphy, C.; Rourke, W.; Pearce, H.; & 
Dufresne, G. (2007). Analysis of veterinary drug residues in fish and shrimp 
composites collected during the Canadian Total Diet Study, 1993-2004. Food 
Additives and Contaminants, vol.24, pp.14-20. 
Tendencia, E. A. & De la Peña, L. D. (2002). Level and percentage recovery of resistance to 
oxytetracycline and oxolinic acid of bacteria from shrimp ponds. Aquaculture, 
vol.213, pp.1-13. 
Tenover, F. C. (2006). Mechanisms of antimicrobial resistance in bacteria. The American 
Journal of Medicine. vol.119, No.6, Suppl. 1, pp.S3-S10.  
Tu, T. H.; Silvestre, F.; Bernard, A. ; Douny, C. ; Phuong, T.N. ; Tao, T.C. ; Maghuin-Rogiste, 
G. & Kestemont, P. (2008). Oxidative stress response of black tiger shrimp (Penaeus 
monodon) to enrofloxacin and to culture system. Aquaculture, vol.285, pp.244-248. 
Uyuguari, M.; Key, P.; Moore, J.; Jackson, K. & Scott, G. (2009). Acute effects of the antibiotic 
oxytetracycline on the bacterial community of the grass shrimp, Palaemonetes Pugio. 
Environmental Toxicology and Chemistry, vol.28, No.12, pp.2715:2724. 
Vandenberghe, J.; Verdonck, L.; Robles-Arozarena, R.; Rivera, G.; Bolland, A.; Balladares, 
M.; Gomez-Gil, B.; Calderon, J.; Sorgeloos, P. & Swings, J. (1999). Vibrios associated 
with Litopenaeus vannamei larvae, postlarvae, broodstock, and hatchery probionts. 
Applied and Environmental Microbiology, vol.65, No.6, pp.2592-2597. 
www.intechopen.com
 
Health and Environment in Aquaculture 
 
214 
Vincent, G. A. & Lotz, J. M. (2007). Advances in reseach of Necrotizing Hepatopancreatitis 
Bacterium (NHPB) affecting penaeid shrimp aquaculture. Reviews Fisheries Science, 
vol.15, pp.63-73. 
Walter, J. P. & Winton, R. J. (2010). Emerging viral diseases of fish and shrimp. Veterinary 
Research, vol.51, pp.51-75. 
Wang, Q.; Liu, Q. & Li, J. (2004). Tissue distribution and elimination of oxytetracycline in 
perch Lateolabrax japonicus and black seabream (Sparus macrocephalus) following oral 
administration. Aquaculture, vol.237, pp.31–40. 
Wen, F.; Shuai, Z.; Kai, Z. & Si-cheng, L. (2007). Pharmacokinetics and tissue distribution of 
enrofloxacin and its metabolite ciprofloxacin in Scylla serrata following oral gavage 
at two salinities. Aquaculture, vol.272, pp.180–187. 
Williams, R. R.; Bell, T.A. & Lightner, D. V. (2002). Shrimp antimicrobial testing: II. Toxicity 
testing and safety determinations for twelve antimicrobials with penaeus shrimp 
larvae. Journal Aquatic Animal Health, vol.4, pp.262–270. 
Xu, W.; Xiaobin, Z.; Xinting, W.; Liping, D. & Gan, Z. (2006). Residues of enrofloxacin, 
furazolidone and their metabolites in Nile tilapia (Oreochromis niloticus). 
Aquaculture, vol.254, pp.1–8. 
Yanong, P. R. & Curtis, W. E. (2005). Pharmacokinetic studies of Florfenicol in Koi Carp and 
threespot gourami Trichogaster trichopterus after oral and intramuscular treatment. 
Journal of Aquatic Health, vol.17, pp.129-137.  
www.intechopen.com
Health and Environment in Aquaculture
Edited by Dr. Edmir Carvalho
ISBN 978-953-51-0497-1
Hard cover, 414 pages
Publisher InTech
Published online 11, April, 2012
Published in print edition April, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Aquaculture has been expanding in a fast rate, and further development should rely on the assimilation of
scientific knowledge of diverse areas such as molecular and cellular biology, and ecology. Understanding the
relation between farmed species and their pathogens and parasites, and this relation to environment is a great
challenge. Scientific community is involved in building a model for aquaculture that does not harm ecosystems
and provides a reliable source of healthy seafood. This book features contributions from renowned
international authors, presenting high quality scientific chapters addressing key issues for effective health
management of cultured aquatic animals. Available for open internet access, this book is an effort to reach the
broadest diffusion of knowledge useful for both academic and productive sector.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
M.C. Bermúdez-Almada and A. Espinosa-Plascencia (2012). The Use of Antibiotics in Shrimp Farming, Health
and Environment in Aquaculture, Dr. Edmir Carvalho (Ed.), ISBN: 978-953-51-0497-1, InTech, Available from:
http://www.intechopen.com/books/health-and-environment-in-aquaculture/the-use-of-antibiotics-in-shrimp-
farming
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
